In this episode of Radio Corona, Gideon Lichfield, editor in chief of MIT Technology Review, will discuss volunteer initiatives that might accelerate the development of a coronavirus vaccine.
Josh Morrison is the Executive Director at Waitlist Zero and part of the team at 1 Day Sooner. Both organizations recruit volunteers to take part of the covid-19 vaccine trials. Ian Haydon is one such volunteer, currently taking part in Moderna's vaccine trial. He explained his decision for us a couple of weeks ago. Arthur Caplan, a Professor of Bioethics at New York University Langone Medical Center and the founding director of the Division of Medical Ethics, will also be talking to us about the ethical questions surrounding the trials.
The regularly updated statistics includes:
Global breakdown of COVID-19 deaths against active cases and recoveries from the disease
How coronavirus cases and COVID-19 deaths have progressed over time
The number of daily new COVID-19 deaths and virus cases in key European countries
COVID-19 death rates per 1,000 infections
World maps showing which countries have been worst hit in terms of deaths and cases
A table breaking down of total and new deaths/cases in each country
Please note the number of cases a country has, and in particular the COVID-19 deaths per 1,000 infections, can be skewed by how much testing for the new coronavirus is done.
There is also a chart showing which age groups were hit hardest by fatal cases of COVID-19 in Italy, giving an insight into who is being worst affected.
abc
gfsdg
adfdahdahfah
adfhdafhafha
dfhadfhahdahahdafha
gadfgdagagadfgadgaga
adfhdafhahdahdahdafbdfa
hreturtyuertyuhj
mgmdghjgdhjghjgj
tyjdgfjgjdghjdgjgdhjdgjhdg
dgmnbasdfgadfgdfgad
ertgdagadgdavbnfrt4562tgadfg
adgdafgare346345tgadfgdh
adf32tgasgadsgagdafg
dagdgadgadfgag436tq3tgadfhadhf
345gdsfdbcsbsfgadfgadgadgfa
35adafh232radfh
dafhahaf43etgadfghadfhdahdahfa
adfhfhah43et3tgadfdfhadhdahbcagadag
9897654edgkjgfd
dfagdaw32r42rfasdgadhgdafhahfadfhahahah
edhhkahdkjahfkdahkdahhfkj
hdafhad8e4ytg8d8fhgdjahdjahdjahfadıhdahjıdahfjıajı
hcsfkhadkfhdjahfdjafhadjf
dhahadhfkadohoadrfhoadhfadh
fsjksfgjkfsgkjfskjkjfskjfskjsgk
dafjhahah8ah8ah8afhuahuahduahfudahjdahdjaha
hkadfhkadfkhadhoda9hdahdahdahıahı
hdahkdkhkkhkdkad
eryeryhdhdahdaf
hnbsfghsfghfsghsfhgfs
rthsfghsfghfsghsfgh
hdahfadfhdahadhfad
ahdfhdahfahdahfcsh
ahdhadfhadfhbcbafgadfgadfg
875746786477ujgdjhgdjd
677537yfshgshfdsshs
745yfyhfshfghfsh
fshhsh67
76867ugdjdj
65jdfg
7judgf
v4gha
54h
43tgadgf
4etgadfg
54gha
daafhadfh
hadfhda43ew4tg
dafhahfadfhdahafh
adfhafhafhadfh
ahdfhafh
hdhf
No comments:
Post a Comment